Logo of Zymo Research

Zymo Research

Zymo Research, a privately owned biotech company founded in 1994, is a global leader in molecular tools for life sciences. Driven by the principle "The Beauty of Science is to Make Things Simple," Zymo Research is dedicated to developing innovative solutions that address complex scientific challenges. Known also as The Epigenetics Company, Zymo Research offers a comprehensive range of technologies, including solutions for sample collection, DNA/RNA purification, library preparation, microbiomics, transcriptomics, epigenomics, genomics, and Next-Generation Sequencing (NGS) services. In addition to its cutting-edge technologies, Zymo Research is committed to sustainability. By engineering environmentally friendly solutions, the company strives to reduce waste and contribute to a more sustainable future through scientific innovation.

Content by Zymo Research

A photo of Zymo Research facilities
| 2 min read
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

A researcher wearing a white lab coat and blue nitrile glove holds a tiny brown glass sample vial with a blue cap in front of an autosampler carousel on a HPLC laboratory analyzer.
Hear an expert perspective on the hidden variables affecting chromatographic methods and how to build more robust, reliable workflows.
Researcher using a laptop with a digital DNA helix and molecular biology graphics overlaid, illustrating connected workflows for sequence design, data management, and therapeutic research.
To keep pace with modern drug discovery, researchers need molecular biology approaches that can support complexity without slowing down the science.
Shaping Science graphic featuring the question “How can labs become truly sustainable?” and a photo of James Connelly, Chief Executive Officer of My Green Lab.
Creating more sustainable laboratories depends on practical changes that strengthen scientific performance while reducing environmental impact.